The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

Drug Intelligence & Clinical Pharmacy: Vol. 15, No. 12, pp. 945-950.
© 1981 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradberry, J.
Right arrow Articles by Raebel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradberry, J.
Right arrow Articles by Raebel, M.

Research Articles

Continuous infusion of naloxone in the treatment of narcotic overdose

JC Bradberry and MA Raebel

Based on the pharmacokinetic parameters of naloxone and the clinical studies discussed in this paper, it is evident that naloxone infusion may be useful in cases of opiate overdose. The infusion protocol presented in Appendix I was formulated based on the pharmacokinetic data available from the literature including Nelson's animal data. An infusion of naloxone was used with apparent success in the two cases presented. Both patients presented with narcotic overdose; although immediate patient history could not be obtained, the presentations were classic for narcotic overdose. It is of note that it may be possible to keep a patient from relapsing into narcosis after overdose by the use of naloxone infusion. Additionally, the extreme safety of naloxone is certainly an advantage with any administration technique. We feel that the administration of continuous infusion of naloxone is an especially important advance in the overdose treatment of longer-acting agents such as methadone, as well as of other narcotics. Therefore, it is recommended that further clinical trials of naloxone by infusion be undertaken, as suggested by J. Nelson, et al. (A protocol for treatment with continuous infusion of naloxone [Narcan] in selected cases of opiate [narcotic] overdose. Austin: University of Texas; May, 1976, unpublished), to further document the effectiveness of an infusion of naloxone in narcotic overdose.


This article has been cited by other articles:


Home page
 Emerg. Med. J.Home page
S F J Clarke, P I Dargan, and A L Jones
Naloxone in opioid poisoning: walking the tightrope
Emerg. Med. J., September 1, 2005; 22(9): 612 - 616.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
K. C. Wilson and J. J. Saukkonen
Acute Respiratory Failure from Abused Substances
J Intensive Care Med, July 1, 2004; 19(4): 183 - 193.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Schulz, P. Gres, and G. Heusch
Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2175 - H2181.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Eissenberg, M. L. Stitzer, G. E. Bigelow, A. R. Buchhalter, and S. L. Walsh
Relative Potency of levo-alpha -Acetylmethadol and Methadone in Humans under Acute Dosing Conditions
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 936 - 945.
[Abstract] [Full Text]


homecopy help contact us subscription past issues search current issue
Copyright © 1981 by Harvey Whitney Books Company.